Theragen Etex Co (XKRX:066700) Total Payout Ratio : 0.00 (As of May. 19, 2025)

View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Theragen Etex Co's current Total Payout Ratio is 0.00.

Theragen Etex Co Total Payout Ratio Historical Data

The historical data trend for Theragen Etex Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co Total Payout Ratio Chart

Theragen Etex Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Payout Ratio

Get a 7-Day Free Trial

0.12

0.03

Theragen Etex Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Theragen Etex Co's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Theragen Etex Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theragen Etex Co's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Theragen Etex Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Theragen Etex Co's Total Payout Ratio falls into.

Save Embed

;

Save Embed

;

Theragen Etex Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Theragen Etex Co's Total Payout Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	-99.136)	/	-39280.684
	=	-0.00

Theragen Etex Co's Total Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-46367.423
	=	0.00

Theragen Etex Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragen Etex Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Total Payout Ratio

Traded in Other Exchanges

N/A

Address

58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR

Website

http://www.theragenetex.com

Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines